Homologous recombination deficiency testing in first-line ovarian cancer. Moore KN, du Bois A. Ann Oncol 2022 Jan 8. pii: S0923-7534(22)00004.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moore KN, du Bois A. Homologous recombination deficiency testing in first-line ovarian cancer. Ann Oncol 2022 Jan 8. pii: S0923-7534(22)00004.
PMID: 35017033